119
Views
4
CrossRef citations to date
0
Altmetric
Case Reports

SUCCESSFUL TREATMENT OF KASABACH-MERRITT SYNDROME WITH VINCRISTINE AND DIAGNOSIS OF THE HEMANGIOMA USING THREE-DIMENSIONAL IMAGING

, MD, , MD, , MD, PhD, , MD, PhD, , MD, PhD & , MD, PhD
Pages 375-380 | Received 28 Aug 2008, Accepted 18 Mar 2009, Published online: 13 Aug 2009

REFERENCES

  • Kasabach H, Merritt K. Capillary hemangioma with extensive purpura. Am J Dis Child. 1940; 59: 1063–1070
  • Hsiao C C, et al. A case of axillary kaposiform hemangioendothelioma resembles a soft tissue sarcoma. J Pediatr Hematol Oncol. 2005; 27: 596–598.
  • Mulliken J B, et al. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 13–2004. A newborn girl with a large cutaneous lesion, thrombocytopenia, and anemia. N Engl J Med. 2004; 350: 1764–1775
  • Panow C, et al. MRI and CT of a haemangioma of the mandible in Kasabach-Merritt syndrome. Neuroradiology. 2000; 42: 215–217.
  • Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 1995; 333: 1757–1763
  • Taki M, et al. Successful treatment with vincristine of an infant with intractable Kasabach–Merritt syndrome. Pediatr Int. 2006; 48: 82–84.
  • Haisley-Royster C., et al. Kasabach-Merritt phenomenon: A retrospective study of treatment with vincristine. J Pediatr Hematol Oncol. 2002; 24: 459–462.
  • White C W, et al. Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. N Engl J Med. 1989; 320: 1197–1200.
  • Garmendía G, et al. Regression of infancy hemangiomas with recombinant IFN-alpha 2b. J Interferon Cytokine Res 2001; 1: 31–38.
  • Hu B, et al. Kasabach-Meritt syndrome-associated kaposiform hemangioendothelioma successfully treated with vincristine, cyclophosphamide, and actinomycin D. Pediatr Hematol Oncol. 1998; 20: 567–569.
  • Hauer J, et al. Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach–Merritt phenomenon using four-drug regimen. Pediatr Blood Cancer. 2007; 49: 852–872

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.